CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net loss	$ (6,709,524)	$ (7,853,509)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,004,633	988,543
Non-cash lease expense	2,504	5,078
Share-based payments for services	218,386	148,858
Equity-based compensation	1,383,909	1,692,831
Common stock contributed to 401(k) plan	48,907	50,178
(Increase)/decrease in assets:
Prepaid expenses	(100,546)	111,537
Supplies used for R&D and manufacturing	(98,765)	212,687
Deposits	(11,884)	0
Increase/(decrease) in liabilities:
Accounts payable	(765,078)	(115,285)
Accrued expenses	(8,924)	13,346
Due to employees	148,454	79,087
Net cash used in operating activities	(4,887,928)	(4,666,649)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(51,650)	(53,580)
Expenditures for patent costs	(13,211)	0
Net cash used in investing activities	(64,861)	(53,580)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	4,980,000	0
Payments of stock issuance costs	(504,913)	(9,010)
Proceeds from the exercise of warrants	0	447,291
Payments on obligations under finance leases	(426,593)	(372,871)
Net cash provided by financing activities	4,048,494	65,410
NET DECREASE IN CASH AND CASH EQUIVALENTS	(904,295)	(4,654,819)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4,145,735	22,672,138
CASH AND CASH EQUIVALENTS, END OF PERIOD	3,241,440	18,017,319
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment purchases included in current liabilities	0	105,318
Finance lease obligation included in accounts payable	714	1,853
Prepaid consulting services paid with issuance of common stock	202,307	91,623
Financing costs included in current liabilities	43,019	0
Cash paid for interest	$ 244,659	$ 277,853